Evaluation of long-term treatment with indomethacin in hereditary hypokalemic salt-losing tubulopathies

Journal of Pediatrics

Volumn 139, Issue 3, 2001, Pages 398-406

  Reinalter, Stephan C ^a,b   Gröne, Hermann Josef ^a,b   Konrad, Martin ^a,b   Seyberth, Hannsjörg W ^a,b   Klaus, Günter ^a,b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM; POTASSIUM CHANNEL; PROSTAGLANDIN E; SPIRONOLACTONE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG USE; DRUG WITHDRAWAL; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPOKALEMIA; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY SIZE; KIDNEY TUBULE DISORDER; LONG TERM CARE; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SALT LOSING NEPHRITIS; TREATMENT OUTCOME; ULTRASOUND;

EID: 0034832453     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2001.117007     Document Type: Article

References (39)

1. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2
2. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK
3. Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: Evidence for genetic heterogeneity
4. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III
5. Mutations in the chloride channel gene, CLCNKB as a cause of Bartter syndrome
6. Gitelman's variant of Bartter's syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl-cotransporter
7. Congenital hypokalemia with hypercalciuria in preterm infants: A hyperprostaglandinuric tubular syndrome different from Bartter syndrome
8. Bartter's syndrome with hyperplasia of renomedullary cells: Successful treatment with indomethacin
9. Prepubertal growth in the hyperprostaglandin E syndrome
10. Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome
11. Prenatal and postnatal management of hyperprostaglandin E syndrome after genetic diagnosis from amnlocytes
12. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis - A new syndrome
13. The juxtaglomerular apparatus in Bartter's syndrome and related tubulopathies: An immunocytochemical and electron microscopic study
14. Bartter syndrome revisited
15. Case study of siblings with juxtaglomerular hyperplasia and secondary aldosteronism associated with severe azotemia and renal rickets - A Bartter's syndrome or disease?
16. Bartter's syndrome, nephrocalcinosis and renal insufficiency
17. A first report: Living related kidney transplantation on a patient with Bartter's syndrome
18. Chronic hypokalaemia with growth retardation, normotensive hyperrenin-hyperaldosteronism ("Bartter's syndromee"), and hypercalciuria
19. Hypokalemic salt losing tubulopathy with associated hearing loss
20. A patient with chronic renal failure due to Bartter's syndrome
21. Nonsteroidal anti-inflammatory drugs: Renal toxicity. Review of pediatric issues
22. Risk of kidney failure associated with the use of acetaminophen, aspirin and nonsteroidal anti-inflammatory drugs
23. National Kidney Foundation Position Paper: Analgesics and the kidney: Summary and recommendations to the scientific advisory board of the National Kidney Foundation from an ad hoc Committee of the National Kidney Foundation
24. Analgesic nephropathy
25. Kaliopenic nephropathy
26. Familial hypokalemia associated with renal interstitial fibrosis
27. Symptoms and course of chronic hypokalemic nephropathy in man
28. Morphologic aspects of low-potassium and low-sodium nephropathy
29. Nephrocalcinosis
30. Hypokalemic tubular disorders: The hyperprostaglandin E syndrome and the Bartter-Gitelman syndrome
31. Marked reduction of Tamm-Horsfall protein synthesis in hyperprostaglandin E syndrome
32. Impaired response to furosemide in hyperprostaglandin E syndrome: Evidence for a tubular defect in the loop of Henle
33. Relation between plasma concentration of indomethacin and its effects on prostaglandin synthesis and platelet aggregation in man
34. Renal calcium deposition in children: Sonographic demonstration of the Anderson-Carr progression
35. High-speed liquid chromatographic analysis of indomethacin in plasma
36. Determination of 7 prostaniods in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quatropole mass spectrometry
37. Quantification of the major urinary metabolite of the E prostaglandins by mass spectrometry: Evaluation of the method's application to clinical studies
38. Developmental nephrology
39. Infantile variant of Bartter syndrome and sensorineural deafness: A new autosomal recessive disorder